Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
The company is planning to expand its plant capacity in in Vapi
The facility is a part of Lupin Manufacturing Solutions
The approved ANDA is therapeutically equivalent to the reference listed drug product
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
This product will be manufactured at Lupin’s Pithampur facility in India
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
